# SLC35B4

## Overview
SLC35B4 is a gene that encodes the protein solute carrier family 35 member B4, which is a member of the solute carrier family involved in nucleotide sugar transport. This protein is primarily responsible for transporting UDP-xylose and UDP-N-acetylglucosamine into the Golgi apparatus and endoplasmic reticulum, playing a critical role in glycosylation processes essential for the synthesis of glycoproteins and glycolipids (Hadley2019Nucleotide; Wex2018SLC35B4). The SLC35B4 protein is characterized by its transmembrane domains and a C-terminal dilysine motif, which is crucial for its localization and function within the cell (Bazan2018Lysine). Its activity is linked to metabolic pathways, including insulin-glucose homeostasis, and it has been implicated in conditions such as diabetes, obesity, and certain cancers (Wex2018SLC35B4; Jiang2022SLC35B4).

## Structure
The SLC35B4 protein is a member of the solute carrier family 35, involved in nucleotide sugar transport. It is encoded by the SLC35B4 gene, which produces two splice variants, with the longer isoform consisting of 331 amino acids (Bazan2018Lysine). The protein is predicted to have an even number of transmembrane domains, with both the N- and C-termini exposed to the cytosol, suggesting a specific orientation within the membrane (Bazan2018Lysine). 

A crucial feature of SLC35B4 is the C-terminal dilysine motif, particularly the lysine at position 329, which is essential for its localization to the endoplasmic reticulum (ER) (Bazan2018Lysine). This motif plays a significant role in the protein's function and cellular localization. The protein is also known to form homodimers or higher oligomers, indicating a quaternary structure that may be important for its transport activity (Bazan2018Lysine).

The study of SLC35B4 has not detailed specific post-translational modifications, but its role in glycosylation processes suggests potential modifications that could influence its function. The protein's structure and motifs are integral to its role in transporting UDP-N-acetylglucosamine and UDP-xylose, which are critical for glycosylation pathways (Bazan2018Lysine).

## Function
SLC35B4 is a gene encoding a protein that functions as a nucleotide sugar transporter, specifically transporting UDP-xylose and UDP-N-acetylglucosamine (UDP-GlcNAc) into the Golgi apparatus and endoplasmic reticulum (ER) (Hadley2019Nucleotide; Wex2018SLC35B4). This transport is crucial for glycosylation processes, which are essential for the synthesis of glycoproteins and glycolipids, impacting cell signaling, adhesion, and maintaining cellular structure (Hadley2019Nucleotide).

In healthy human cells, SLC35B4 is localized primarily in the Golgi apparatus and ER, with its localization dependent on a C-terminal dilysine motif, particularly lysine at position 329 (Hadley2019Nucleotide; Bazan2018Lysine). The protein's activity is linked to glucose metabolism, as it is involved in insulin-glucose homeostasis in the liver, influencing conditions like diabetes and obesity (Wex2018SLC35B4). SLC35B4 is hypothesized to affect the insulin pathway by altering gluconeogenesis and glycogenolysis, potentially improving insulin function in inhibiting glucose production (Wex2018SLC35B4).

SLC35B4's role in transporting UDP-GlcNAc is significant for O-GlcNAcylation, a post-translational modification that regulates protein subcellular localization, stability, or activity (Wex2018SLC35B4). This modification is crucial for the regulation of various metabolic pathways, including those involving the insulin receptor and other proteins linked to metabolic disorders (Yazbek2011Deep).

## Clinical Significance
Alterations in the expression of the SLC35B4 gene have been linked to several metabolic disorders, particularly those related to diabetes and obesity. Increased expression of SLC35B4 has been observed in the adipose tissue of obese individuals, and its expression is associated with insulin resistance and gluconeogenesis, especially in the context of obesity-induced Type 2 Diabetes (T2D) (Wex2018SLC35B4). A single nucleotide polymorphism (SNP) in SLC35B4 is associated with variations in body mass index, metabolic syndrome, fasting glucose, and pro-insulin levels, indicating its role in metabolic regulation (Yazbek2011Deep).

In liver cells, SLC35B4 expression affects hepatic glucose production and insulin sensitivity, with its expression being responsive to glucose levels (Wex2018SLC35B4). Knockdown studies in HepG2 liver cell lines have shown that decreased SLC35B4 expression leads to changes in the liver proteome, impacting proteins involved in diabetes and insulin resistance pathways (Wex2018SLC35B4). These findings suggest that SLC35B4 plays a significant role in the pathogenesis of diabetes through its influence on protein glycosylation and glucose metabolism (Wex2018SLC35B4).

Additionally, SLC35B4 has been implicated in cancer biology, with elevated expression levels observed in hepatocellular carcinoma (HCC) tissues. This overexpression is associated with poor prognosis and is crucial for the proliferation and tumorigenesis of HCC cells (Jiang2022SLC35B4).


## References


[1. (Bazan2018Lysine) Bożena Bazan, Maciej Wiktor, Dorota Maszczak-Seneczko, Teresa Olczak, Beata Kaczmarek, and Mariusz Olczak. Lysine at position 329 within a c-terminal dilysine motif is crucial for the er localization of human slc35b4. PLOS ONE, 13(11):e0207521, November 2018. URL: http://dx.doi.org/10.1371/journal.pone.0207521, doi:10.1371/journal.pone.0207521. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0207521)

[2. (Wex2018SLC35B4) Brigitte Wex, Rémi M. Safi, Gregory Antonios, Perla Z. Zgheib, Dania B. Awad, Firas H. Kobeissy, Rami A. Mahfouz, Marwan M. El-Sabban, and Soha N. Yazbek. Slc35b4, an inhibitor of gluconeogenesis, responds to glucose stimulation and downregulates hsp60 among other proteins in hepg2 liver cell lines. Molecules, 23(6):1350, June 2018. URL: http://dx.doi.org/10.3390/molecules23061350, doi:10.3390/molecules23061350. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules23061350)

[3. (Yazbek2011Deep) Soha N. Yazbek, David A. Buchner, Jonathan M. Geisinger, Lindsay C. Burrage, Sabrina H. Spiezio, Gabriel E. Zentner, Chang-Wen Hsieh, Peter C. Scacheri, Colleen M. Croniger, and Joseph H. Nadeau. Deep congenic analysis identifies many strong, context-dependent qtls, one of which, slc35b4, regulates obesity and glucose homeostasis. Genome Research, 21(7):1065–1073, April 2011. URL: http://dx.doi.org/10.1101/gr.120741.111, doi:10.1101/gr.120741.111. This article has 50 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1101/gr.120741.111)

[4. (Hadley2019Nucleotide) Barbara Hadley, Thomas Litfin, Chris J. Day, Thomas Haselhorst, Yaoqi Zhou, and Joe Tiralongo. Nucleotide sugar transporter slc35 family structure and function. Computational and Structural Biotechnology Journal, 17:1123–1134, 2019. URL: http://dx.doi.org/10.1016/j.csbj.2019.08.002, doi:10.1016/j.csbj.2019.08.002. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.csbj.2019.08.002)

[5. (Jiang2022SLC35B4) Tao Jiang, Jinghong Yang, Huohong Yang, Wancheng Chen, Kaiyuan Ji, Yang Xu, and Lili Yu. Slc35b4 stabilizes c-myc protein by o-glcnacylation in hcc. Frontiers in Pharmacology, March 2022. URL: http://dx.doi.org/10.3389/fphar.2022.851089, doi:10.3389/fphar.2022.851089. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2022.851089)